Arena Pharma (ARNA) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Financial Fact:
Net loss per share allocable to common stockholders, basic: -0.05
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net loss per share allocable to common stockholders, basic: -0.05
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Arena Pharma (NASDAQ: ARNA) reported Q3 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $19 million versus the consensus estimate of $13.99 million.
For earnings history and earnings-related data on Arena Pharma (ARNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
- Radnostix revenue falls 27% amid product recalls and FDA actions
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
